BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6573527)

  • 1. Cutaneous melanoma in relation to exogenous hormones and reproductive factors.
    Holly EA; Weiss NS; Liff JM
    J Natl Cancer Inst; 1983 May; 70(5):827-31. PubMed ID: 6573527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous melanoma in women: ovulatory life, menopause, and use of exogenous estrogens.
    Holly EA; Cress RD; Ahn DK
    Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):661-8. PubMed ID: 7881339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
    Holman CD; Armstrong BK; Heenan PJ
    Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues.
    Lens M; Bataille V
    Cancer Causes Control; 2008 Jun; 19(5):437-42. PubMed ID: 18197460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
    Osterlind A; Tucker MA; Stone BJ; Jensen OM
    Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis.
    Gandini S; Iodice S; Koomen E; Di Pietro A; Sera F; Caini S
    Eur J Cancer; 2011 Nov; 47(17):2607-17. PubMed ID: 21620689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal melanoma, hormonal and reproductive factors in women.
    Holly EA; Aston DA; Ahn DK; Kristiansen JJ; Char DH
    Cancer Res; 1991 Mar; 51(5):1370-2. PubMed ID: 1997174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.
    Naldi L; Altieri A; Imberti GL; Giordano L; Gallus S; La Vecchia C;
    Ann Epidemiol; 2005 Aug; 15(7):545-50. PubMed ID: 16029848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptive use and malignant melanoma.
    Bain C; Hennekens CH; Speizer FE; Rosner B; Willett W; Belanger C
    J Natl Cancer Inst; 1982 Apr; 68(4):537-9. PubMed ID: 6951070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use.
    Holly EA; Cress RD; Ahn DK
    Am J Epidemiol; 1995 May; 141(10):943-50. PubMed ID: 7741124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.